February 2022

Six weeks of 10-minute sessions using a smartphone app reduced depressive symptoms in patients with diabetes or hypertension in Brazil and Peru, according to 2 recent randomized clinical trials.

Comparison of Relapse Rates for Disease-Modifying Therapies for Multiple Sclerosis Using Real-World Data

Multiple Sclerosis

February 2022

A comparative effectiveness study of real-world data from patients with multiple sclerosis showed that dimethyl fumarate and fingolimod were equivalent and rituximab was superior to natalizumab for reducing relapse.

Classifying Migraine Subtypes

Migraine

February 2022

Migraines may be classified into 3 subtypes based on headache intensity, frequency, and the presence of photophobia and phonophobia, according to a new analysis.

Sleep Depth May Be Correlated with Heart Rate After Seizures During Sleep

Epilepsy

February 2022

For seizures that occur during sleep, deeper sleep in the 5 minutes preceding a seizure was correlated with a reduced heart rate after the seizure, according to a recent study.

Relapse in Patients with Dementia-Related Psychosis After Discontinuation of Pimavanserin

Alzheimer Disease/Dementia

February 2022

Discontinuation of pimavanserin for dementia-related psychosis was associated with a higher rate of relapse compared with continuation, according to a recent randomized discontinuation trial that was stopped early for efficacy.